What is the primary mechanism by which prostaglandin analogs reduce intraocular pressure in glaucoma?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the Ophthalmic Medications Test with flashcards and multiple choice questions. Each question includes hints and explanations to enhance your understanding. Gear up for your exam!

Multiple Choice

What is the primary mechanism by which prostaglandin analogs reduce intraocular pressure in glaucoma?

Explanation:
Prostaglandin analogs lower intraocular pressure mainly by increasing the outflow of aqueous humor through the uveoscleral pathway. They bind FP receptors in the ciliary muscle, triggering remodeling of the extracellular matrix and widening spaces that allow fluid to exit the eye via the uveoscleral tract. This outward flow boost reduces IOP without primarily suppressing aqueous production. In contrast, drugs that decrease production (like carbonic anhydrase inhibitors) or that primarily enhance trabecular outflow (associated with other drug classes) do not reflect the main action of prostaglandin analogs.

Prostaglandin analogs lower intraocular pressure mainly by increasing the outflow of aqueous humor through the uveoscleral pathway. They bind FP receptors in the ciliary muscle, triggering remodeling of the extracellular matrix and widening spaces that allow fluid to exit the eye via the uveoscleral tract. This outward flow boost reduces IOP without primarily suppressing aqueous production. In contrast, drugs that decrease production (like carbonic anhydrase inhibitors) or that primarily enhance trabecular outflow (associated with other drug classes) do not reflect the main action of prostaglandin analogs.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy